Integration Health: Recognized Fastest Growing Company in Southwest for ECMO Expansion

Integration Health Recognized as Fastest Growing Company

Integration Health has recently garnered recognition on the 2026 Inc. Regionals: Southwest list, highlighting its rapid growth and commitment to healthcare innovation. This achievement confirms the company's relentless pursuit of expanding access to life-saving ECMO (Extracorporeal Membrane Oxygenation) and perfusion care across the Southwestern United States.

Founded in August 2025, Integration Health was created as a strategic platform that melds together Innovative ECMO Concepts and perfusion services under one umbrella. Since its inception, the company has engaged in aggressive growth strategies, including the acquisition of ECMO Advantage in September 2025 and Perfusion Life in March 2026. As a result, Integration Health has established a network that includes over 1,300 credentialed perfusionists and serves more than 100 facilities across nearly all 50 states, as well as Canada.

The healthcare landscape has recognized the urgent need for specialized ECMO support, a demand catalyzed by the increasing awareness of its life-saving capabilities. John Martin, the CEO of Integration Health, expressed gratitude for this recognition, emphasizing that it underscores the expansion of ECMO and perfusion capabilities in various hospitals. He noted, "Being named one of the fastest-growing companies in the Southwest reflects the hospitals that now have ECMO and perfusion capabilities they didn't have before — and the patients whose lives have been saved as a result." This statement highlights the core mission of Integration Health, which revolves around saving lives through advanced medical technologies.

The impressive growth rate of the companies featured in the Inc. Regionals Southwest list is noteworthy; from 2022 to 2024, these businesses reported a median growth rate of 79%, cumulatively adding 9,633 jobs and injecting $5.2 billion into the regional economy. Integration Health's trajectory aligns with this pattern as hospitals increasingly recognize the clinical and financial value of ECMO. As a direct response, Integration Health has been providing critical support, program development, education, and transport services that enable hospitals to implement these advanced therapies sustainably.

Integration Health's mission remains crystal clear: to broaden access to therapies that can save lives. With the growing demand for ECMO, especially as hospitals recognize its capabilities, Integration Health is strategically positioned to fulfill this need. Each new hospital partnership represents a critical opportunity to provide patients with access to life-saving care that was previously unavailable.

As the company looks to build on its momentum, further expansions of service offerings and collaborations are on the horizon. The healthcare industry is continuously evolving, and Integration Health is at the forefront, eager to meet the demands of patients and hospitals alike. Their commitment to excellence and innovation, coupled with their proactive approach in addressing healthcare gaps, signals a promising future for the organization.

Additionally, Integration Health's focus on training serves to enhance quality care delivery. Annually, the company trains over 1,000 providers, ensuring that personnel is equipped to handle the complexities of ECMO and perfusion support. The training is conducted in collaboration with various healthcare institutions, allowing Integration Health to maintain clinical excellence while executing seamless service delivery.

In conclusion, the accolades bestowed upon Integration Health not only celebrate their achievements but also reinforce the importance of expanding healthcare capabilities in underserved communities. As they continue to bridge gaps in ECMO and perfusion care, they exemplify the spirit of innovation and dedicated service in the healthcare sector. Their journey, marked by strategic growth and unwavering commitment to patient care, inspires hope for many who rely on these critical life-saving therapies.